The effects of deep brain stimulation on sleep in Parkinson's disease
- PMID: 21339905
- PMCID: PMC3036959
- DOI: 10.1177/1756285610392446
The effects of deep brain stimulation on sleep in Parkinson's disease
Abstract
Sleep dysfunction is a common nonmotor symptom experienced by patients with Parkinson's disease (PD). Symptoms, including excessive daytime sleepiness, sleep fragmentation, rapid eye movement (REM) sleep behavior disorder and others, can significantly affect quality of life and daytime functioning in these patients. Recent studies have evaluated the effects of deep brain stimulation (DBS) at various targets on sleep in patients with advanced PD. Several of these studies have provided evidence that subthalamic nucleus DBS improves subjective and objective measures of sleep, including sleep efficiency, nocturnal mobility, and wake after sleep onset (minutes spent awake after initial sleep onset). Although fewer studies have investigated the effects of bilateral internal globus pallidus and thalamic ventral intermedius DBS on sleep, pallidal stimulation does appear to improve subjective sleep quality. Stimulation of the pedunculopontine nucleus has recently been proposed for selected patients with advanced PD to treat severe gait and postural dysfunction. Owing to the role of the pedunculopontine nucleus in modulating behavioral state, the impact of stimulation at this target on sleep has also been evaluated in a small number of patients, showing that pedunculopontine nucleus DBS increases REM sleep. In this review, we discuss the effects of stimulation at these various targets on sleep in patients with PD. Studying the effects of DBS on sleep can enhance our understanding of the pathophysiology of sleep disorders, provide strategies for optimizing clinical benefit from DBS, and may eventually guide novel therapies for sleep dysfunction.
Keywords: Parkinson’s disease; deep brain stimulation; globus pallidus; pedunculopontine nucleus; sleep; subthalamic nucleus; ventral intermediate nucleus of the thalamus.
Similar articles
-
A 3-year observation of excessive daytime sleepiness after subthalamic deep brain stimulation in patients with Parkinson's disease.Clin Neurol Neurosurg. 2020 May;192:105721. doi: 10.1016/j.clineuro.2020.105721. Epub 2020 Feb 4. Clin Neurol Neurosurg. 2020. PMID: 32058203
-
The Impact of Deep Brain Stimulation on Sleep in Parkinson's Disease: An update.J Parkinsons Dis. 2020;10(2):393-404. doi: 10.3233/JPD-191862. J Parkinsons Dis. 2020. PMID: 32250316 Free PMC article. Review.
-
A Pilot Study Assessing the Effects of Pallidal Deep Brain Stimulation on Sleep Quality and Polysomnography in Parkinson's Patients.Neuromodulation. 2016 Oct;19(7):724-730. doi: 10.1111/ner.12442. Epub 2016 May 17. Neuromodulation. 2016. PMID: 27186939 Free PMC article.
-
Effects of Deep Brain Stimulation on Sleep-Wake Disturbances in Patients with Parkinson's Disease: A Narrative Review.Curr Neuropharmacol. 2021;19(10):1716-1727. doi: 10.2174/1570159X19666210215115718. Curr Neuropharmacol. 2021. PMID: 33588729 Free PMC article. Review.
-
Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: which target?Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S165-7. doi: 10.1016/S1353-8020(11)70051-7. Parkinsonism Relat Disord. 2012. PMID: 22166422 Review.
Cited by
-
Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.Oman Med J. 2015 Jan;30(1):3-10. doi: 10.5001/omj.2015.02. Oman Med J. 2015. PMID: 25829994 Free PMC article. Review.
-
Deep Brain Stimulation and Sleep-Wake Disturbances in Parkinson Disease: A Review.Front Neurol. 2018 Aug 27;9:697. doi: 10.3389/fneur.2018.00697. eCollection 2018. Front Neurol. 2018. PMID: 30210429 Free PMC article. Review.
-
Amelioration of L-Dopa-Associated Dyskinesias with Triterpenoic Acid in a Parkinsonian Rat Model.Neurotox Res. 2016 Jan;29(1):126-34. doi: 10.1007/s12640-015-9567-3. Epub 2015 Oct 12. Neurotox Res. 2016. PMID: 26459303
-
Investigation of the nonmotor symptoms in patients with STN-DBS therapy in comparison with those without STN-DBS.J Neural Transm (Vienna). 2024 Aug;131(8):931-940. doi: 10.1007/s00702-024-02778-y. Epub 2024 Apr 30. J Neural Transm (Vienna). 2024. PMID: 38684577
-
Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?Ther Adv Neurol Disord. 2012 Jan;5(1):23-41. doi: 10.1177/1756285611423412. Ther Adv Neurol Disord. 2012. PMID: 22276074 Free PMC article.
References
-
- Alessandro S., Ceravolo R., Brusa L., Pierantozzi M., Costa A., Galati S., et al. (2010) Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: Focus on sleep and cognitive domains. J Neurol Sci 289: 44–48 - PubMed
-
- Amara A., Walker H., Guthrie S., Cutter G., Standaert D., Watts R.L. (2010) Unilateral STN DBS improves sleep in Parkinson’s disease. In: American Academy of Neurology annual meeting 15 April 2010, Toronto, ON, Canada, American Academy of Neurology
-
- Anderson V.C., Burchiel K.J., Hogarth P., Favre J., Hammerstad J.P. (2005) Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 62: 554–560 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources